Skip to content
Review Open access

Contemporary Challenges and Strategies for Diagnosing and Managing in Type 2 Myocardial Infarction: A Narrative Review

Aug 2026 · Journal of Personalized Medicine · Vol 16, pp. 438 · 0 citations · 120 references
Medicine

TL;DR

The review emphasizes the need for a multimodal approach, integrating biomarkers, individualized clinical decision-making and advanced cardiac imaging, as differentiation between T2MI and T1MI remains a significant challenge.

Abstract

Type 2 myocardial infarction (T2MI) occurs secondary to an imbalance between myocardial oxygen supply and demand, with systemic conditions serving as the primary precipitating factors. T2MI predominantly affects older adults and is frequently accompanied by multiple chronic comorbidities. Therefore, it often has an atypical clinical course and remains a significant diagnostic and therapeutic challenge, particularly given the lack of standardized clinical guidelines. Furthermore, the diagnosis of T2MI in women is especially challenging due to sex-related differences in biomarker kinetics and atypical symptom presentation. The aim of this review is to summarize current knowledge on T2MI, discuss modern diagnostic tools, and analyze sex-related differences in this context in order to identify future directions for the development of therapeutic guidelines. The review emphasizes the need for a multimodal approach, integrating biomarkers, individualized clinical decision-making and advanced cardiac imaging, as differentiation between T2MI and T1MI remains a significant challenge. Therefore, both non-invasive and invasive diagnostic strategies may be required to accurately identify patients with T2MI. Although routine coronary angiography in T2MI is not clearly supported by current evidence, it may be useful as a decisive tool for reclassification, particularly when the clinical presentation is ambiguous.

Read PDF

Similar papers

Review Open access Aug 2026

Diabetic Cardiomyopathy: Distinct Clinical Entity or Manifestation of Metabolic Heart Disease?

Background/Objectives: Type 2 diabetes mellitus (T2DM) is a global epidemic strongly associated with an increased risk of heart failure, independent of coronary artery disease or hypertension. This condition, historically termed diabetic cardiomyopathy (DCM) and recently redefined as “diabetic myocardial disorder,” rem...

S. D'Elia, Rosa Franzese, Ettore Luisi et al. · 1 citation
Review Open access Aug 2026

Clinical Utility of NT-proBNP in the Diagnosis and Management of Heart Failure: A Comprehensive Review

Background: Heart failure (HF) is a major global public health problem associated with high morbidity, mortality, and healthcare costs. Early diagnosis and timely management are essential to improve clinical outcomes. N-terminal pro-B-type natriuretic peptide (NT-proBNP), a biomarker released in response to myocardial...

Abhinav P Kanigicherla, Unnagiri Adinarayana, Vasamsetti Kumar Swamy et al. · 0 citations
Review Open access Aug 2026

Frontiers in the diagnosis and treatment of sepsis-induced cardiomyopathy: current status and prospects

This systematic review outlines the overall research landscape of SIC, including pathological mechanisms, epidemiological profiles, updated diagnostic systems and innovative therapeutic strategies, as well as existing challenges and future research priorities.

Nai-Hong Zhang, Neng Wang, Jia-Wen He et al. · 0 citations
Review Open access Sep 2026

Risk Stratification and Contemporary Therapeutic Strategies in Pediatric Pulmonary Hypertension: A Narrative Review

Background: Pediatric pulmonary hypertension (PH) is a rare, heterogeneous disease marked by progressive pulmonary vascular resistance and right ventricular pressure overload, with significant morbidity and mortality. Targeted pharmacotherapy has advanced, yet management is complicated by diverse causes, developmental...

Agnieszka Zielińska, Z. Kamińska, Gabriela Senda et al. · 0 citations
Review Open access Sep 2026

Moderate aortic stenosis: diagnostic pitfalls and the role of multimodality imaging in risk stratification and clinical management

Moderate aortic stenosis (AS) has traditionally been considered a transitional and relatively benign stage of valvular disease. Yet, contemporary evidence shows that it is associated with substantial morbidity and mortality even before progression to severe AS. This paper synthesizes current evidence on the limitations...

G. Santangelo, A. Maloberti, C. Tognola et al. · 0 citations
Review Open access Sep 2026

From diagnosis to decision-making: the evolving role of biomarkers in acute pancreatitis

Acute pancreatitis (AP) presents clinicians with a fundamental challenge: while the majority of patients recover with minimal intervention, a significant minority deteriorate rapidly, developing organ failure and life-threatening complications. Early identification of high-risk patients remains one of the most clinical...

Abhijeet Shridhar, Jameel Ahmad, F. Ahmad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.